Summary proceedings of 30th AGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Limited held its 30th Annual General Meeting for FY 2024-25 on Tuesday, September 30, 2025, via video conferencing from 09:30 AM to 09:54 AM. 65 members attended the meeting, where all 7 directors and the Company Secretary were present through VC. Nine resolutions were tabled, including adoption of audited financial statements (standalone and consolidated) for the year ended March 31, 2025, re-appointment of retiring director S. Manoj Kumar Reddy, and approval of related party transactions for FY 2025-26. Key resolutions also covered re-appointment of Chairman & MD S. Nagi Reddy, Whole-Time Director & CFO S. Koni Reddy, and Whole-Time Director S. Manoj Kumar Reddy. A new Non-Executive Independent Director, Mr. Satyam Reddy Gopidi, was proposed for appointment, and PSK & Associates was appointed as Secretarial Auditor. Voting was conducted through remote e-voting and e-voting at the AGM; results are pending and will be filed with BSE shortly.
This is a routine procedural disclosure confirming the AGM was held in compliance with SEBI and MCA regulations. No material financial numbers or strategic surprises were disclosed in the proceedings. Shareholders should watch for the separate voting results filing to confirm whether all resolutions, including the related party transactions and director re-appointments, were passed.